Karen C. M. Moraes

Karen C. M. Moraes

Auto-generated profile, based on publicly available information

Karen C. M. Moraes

Universidade Estadual Paulista “Júlio de Mesquita Filho”, Brasil; Universidade Estadual Paulista “Júlio de Mesquita Filho”, Brasil; Universidade Estadual Paulista “Júlio de Mesquita Filho”, Brasil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
KMKaren C. M. Moraes
Karen C. M. Moraes
JMJacques Montagne
Jacques Montagne
Animal experimentation is limited by unethical procedures, time-consuming protocols, and high cost. Thus, the development of innovative approaches for disease treatment based on alternative models in a fast, safe, and economic manner is an important, yet challenging goal. In this paradigm, the fruit-fly Drosophila melanogaster has become a powerful model for biomedical research, considering its short life cycle and low-cost maintenance. In addition, biological processes are conserved and homologs of ∼75% of human disease-related genes are found in the fruit-fly. Therefore, this model has been used in innovative approaches to evaluate and validate the functional activities of candidate molecules identified via in vitro large-scale analyses, as putative agents to treat or reverse pathological conditions. In this context, Drosophila offers a powerful alternative to investigate the molecular aspects of liver diseases, since no effective therapies are available for those pathologies. Non-alcoholic fatty liver disease is the most common form of chronic hepatic dysfunctions, which may progress to the development of chronic hepatitis and ultimately to cirrhosis, thereby increasing the risk for hepatocellular carcinoma (HCC). This deleterious situation reinforces the use of the Drosophila model to accelerate functional research aimed at deciphering the mechanisms that sustain the disease. In this short review, we illustrate the relevance of using the fruit-fly to address aspects of liver pathologies to contribute to the biomedical area.

14 September 2020 in Expert Review of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
LRLetícia F Ramos
Letícia F Ramos
CSCaio M Silva
Caio M Silva
CPCamila C Pansa
Camila C Pansa
KMKaren C M Moraes
Karen C M Moraes
Non-alcoholic fatty liver disease (NAFLD) affects ~25% of world population and cases have increased in recent decades. These anomalies have several etiologies; however, obesity and metabolic dysfun...

17 March 2020 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CSCaio Mateus Silva
Caio Mateus Silva
GFGustavo Duarte Ferrari
Gustavo Duarte Ferrari
LALuciane Carla Alberici
Luciane Carla Alberici
OMOsmar EMPRESARIAL BASICO Malaspina
Osmar EMPRESARIAL BASICO Malaspina
KMKaren C. M. Moraes
Karen C. M. Moraes

4 December 2023 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
CPCamila C. Pansa
Camila C. Pansa
LMLetícia R. Molica
Letícia R. Molica
FJFabiano C. de Oliveira Júnior
Fabiano C. de Oliveira Júnior
LSLara C. Santello
Lara C. Santello
KMKaren C. M. Moraes
Karen C. M. Moraes

22 August 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CSCaio Mateus da Silva
Caio Mateus da Silva
FCFlávio Henrique Caetano
Flávio Henrique Caetano
FPFranco Dani Campos Pereira
Franco Dani Campos Pereira
MMMaria Aparecida Marin-Morales
Maria Aparecida Marin-Morales
KSKumiko Koibuchi Sakane
Kumiko Koibuchi Sakane
KMKaren C. M. Moraes
Karen C. M. Moraes
Chronic hepatic diseases are serious problems worldwide, which may lead to the development of fibrosis and eventually cirrhosis. Despite the significant number of people affected by hepatic fibrosis, no effective treatment is available. In the liver, hepatic stellate cells are the major fibrogenic cell type that play a relevant function in chronic liver diseases. Thus, the characterization of components that control the fibrogenesis in the hepatic stellate cells is relevant in supporting the development of innovative therapies to treat and/or control liver fibrosis. The present study investigated the effects of Baccharis dracunculifolia D.C. and Plectranthus barbatus Andrews medicinal plant extracts in LX-2 transdifferentiation. LX-2 is a human immortalized hepatic stellate cell that can transdifferentiate in vitro from a quiescent-like phenotype to a more proliferative and activated behavior, and it provides a useful platform to assess antifibrotic drugs. Then, the antifibrotic effects of hydroalcoholic extracts of Baccharis dracunculifolia and Plectranthus barbatus medicinal plants on LX-2 were evaluated. The results in our cellular analyses, under the investigated concentrations of the plant extracts, indicate no deleterious effects on LX-2 metabolism, such as toxicity, genotoxicity, or apoptosis. Moreover, the extracts induced changes in actin filament distribution of activated LX-2, despite not affecting the cellular markers of transdifferentiation. Consistent effects in cellular retinoid metabolism were observed, supporting the presumed activity of the plant extracts in hepatic lipids metabolism, which corroborated the traditional knowledge about their uses for liver dysfunction. The combined results suggested a potential hepatoprotective effect of the investigated plant extracts reinforcing their safe use as coadjuvants in treating imbalanced liver lipid metabolism.

22 November 2023 in Toxicology in Vitro
Verified
Journal Article
Closed access
IBI.I. Barreto
I.I. Barreto
LGL.R. Gonçalves
L.R. Gonçalves
ACA.F. Corrêa
A.F. Corrêa
MMM.A. Marin-Morales
M.A. Marin-Morales
KMK.C.M. Moraes
K.C.M. Moraes